Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
TANDEM DIABETES CARE INC (TNDM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 8-K Quarterly results
08/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Tandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial Guidance"
06/12/2023 SC 13G/A FMR LLC reports a 9.4% stake in TANDEM DIABETES CARE INC
05/31/2023 SD Form SD - Specialized disclosure report:
05/10/2023 SC 13G/A Capital World Investors reports a 10% stake in Tandem Diabetes Care, Inc.
04/06/2023 SC 13G/A BlackRock Inc. reports a 14.3% stake in TANDEM DIABETES CARE INC
02/22/2023 8-K Quarterly results
Docs: "Tandem Diabetes Care Announces Fourth Quarter 2022 Financial Results and Full Year 2023 Financial Guidance",
"Tandem Diabetes Care Appoints New Chair of Board of Directors"
02/22/2023 10-K Annual Report for the period ended December 31, 2022
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A FMR LLC reports a 15% stake in TANDEM DIABETES CARE INC
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.5% stake in Tandem Diabetes Care Inc.
01/24/2023 SC 13G BlackRock Inc. reports a 9.9% stake in TANDEM DIABETES CARE INC
01/23/2023 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical"
01/10/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook"
12/13/2022 8-K Quarterly results
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/02/2022 8-K Quarterly results
08/03/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 8-K Quarterly results
Docs: "Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance"
07/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/16/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/27/2022 SD Form SD - Specialized disclosure report:
05/04/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 8-K Quarterly results
Docs: "Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance"
04/13/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/13/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/30/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/22/2022 10-K Annual Report for the period ended December 31, 2021
02/22/2022 8-K Quarterly results
02/16/2022 8-K Other Events  Interactive Data
Docs: "Tandem Diabetes Care Announces FDA Clearance for the t:slim X2 Insulin Pump to Bolus Using the t:connect Mobile App First Smartphone App FDA cleared for Insulin Delivery on Both iOS and Android Operating Systems"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy